# Vaginal Microbiome Exposure and Immune Responses in C-section Infants

> **NCT03567707** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 114 (actual)

## Conditions studied

- Allergic Diseases
- Asthma

## Interventions

- **DRUG:** Vaginal seeding
- **DRUG:** Placebo Seeding
- **OTHER:** Standard care
- **OTHER:** Post-seeding Care

## Key facts

- **NCT ID:** NCT03567707
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-28
- **Primary completion:** 2025-01-30
- **Final completion:** 2027-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-11-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567707, "Vaginal Microbiome Exposure and Immune Responses in C-section Infants". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03567707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*